semaglutide fda approval for weight loss approves higher dose of Wegovy to increase patient Semaglutide FDA Approval vs Compounded

--- ## Retatrutide FDA Approval Timeline: What to Expect As of July 2026, Eli Lilly's TRIUMPH Phase 3 program is underway with four trials (TRIUMPH-1 through TRIUMPH-4) covering obesity, type 2 diabetes, and metabolic dysfunction-associated steatohepatitis (MASH)

Patient reports still matter even when the label is quiet

So the cleanest summary is not better than oral semaglutide. It is stronger on key outcomes, with a real tolerability cost attached. News coverage often throws around clinical and regulatory terms as if readers already know the language

There was no evidence of difference in fasting plasma insulin (13.2 vs

ECOG performance status grades were 0, 1 and 2 in 14, 21 an 1 patient